No article text was recorded for this version.
dual-pathway inhibition
Version 2 of 252 papers65 conceptsfrozen 2026-10-04
Papers in this version
- Blog: A combinatorial screening protocol for identifying novel and highly potent dual-target inhibitor of BRD4 and STAT3 for kidney cancer therapy
- Blog: Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas
- Blog: Erianin induces apoptosis and pyroptosis via MAPK/ERK and PI3K/Akt pathways and synergizes with anlotinib in anaplastic thyroid carcinoma
- Blog: Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial
- Blog: AB0055 THE ROLES OF OX40L AND TNF BISPECIFIC ANTIBODY IN OSTEOCLASTOGENESIS
- Blog: Genetic Selection of Peptide Aptamers That Interact and Inhibit Both Small Protein B and Alternative Ribosome-Rescue Factor A of Aeromonas veronii C4
- Blog: Characterization of the Src-regulated kinome identifies SGK1 as a key mediator of Src-induced transformation
- Blog: Enzalutamide-Resistant Progression of Castration-Resistant Prostate Cancer Is Driven via the JAK2/STAT1-Dependent Pathway
- Blog: Discovery and identification of potential anti-melanogenic active constituents of Bletilla striata by zebrafish model and molecular docking
- Blog: TNFa inhibitor C87 sensitizes EGFRvIII transfected glioblastoma cells to gefitinib by a concurrent blockade of TNFa signaling
- Blog: Discovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor
- Blog: Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment
- Blog: FGF19 Is Coamplified With CCND1 to Promote Proliferation in Lung Squamous Cell Carcinoma and Their Combined Inhibition Shows Improved Efficacy
- Blog: PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer
- Blog: Interference With Quorum-Sensing Signal Biosynthesis as a Promising Therapeutic Strategy Against Multidrug-Resistant Pathogens
- Blog: TRPS1 regulates the opposite effect of progesterone via RANKL in endometrial carcinoma and breast carcinoma
- Blog: Integrative network analysis identifies potential targets and drugs for ovarian cancer
- Blog: Disruption of NCOA2 by recurrent fusion with LACTB2 in colorectal cancer
- Blog: Treatment strategy for advanced or metastatic NSCLC patients with EGFR mutations after TKI-resistance: A scoping review
- Blog: Real-World Data on Morphological and Functional Responses After Switching to Faricimab in Recalcitrant, Chronic Diabetic Macular Edema
- Blog: Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort
- Blog: Phase I dose escalation study and pilot efficacy analysis of LXI-15029, a novel mTOR dual inhibitor, in Chinese subjects with advanced malignant solid tumors
- Blog: Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic Cells
- Blog: Advances in the intrinsic signaling pathway interactions and clinical translation of HR+/HER2+ breast cancer
- Blog: Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer
- Blog: SHROOM2 inhibits tumor metastasis through RhoA–ROCK pathway-dependent and -independent mechanisms in nasopharyngeal carcinoma
- Blog: Oncogenic EML4-ALK assemblies suppress growth factor perception and modulate drug tolerance
- Blog: The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis
- Blog: Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case
- Blog: BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair
- Blog: Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma
- Blog: Real-world efficacy and safety of inetetamab-based therapy in HER2-positive metastatic breast cancer patients with prior exposure to trastuzumab
- Blog: MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2
- Blog: DET induces apoptosis and suppresses tumor invasion in glioma cells via PI3K/AKT pathway
- Blog: <i>Lactobacillus gallinarum</i>-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis
- Blog: Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
- Blog: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer
- Blog: Identification of new EphA4 inhibitors by virtual screening of FDA-approved drugs
- Blog: Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies
- Blog: Stimulator of interferon response cGAMP interactor overcomes ERBB2-mediated apatinib resistance in head and neck squamous cell carcinoma
- Blog: Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer
- Blog: Photo-controlled co-delivery of verteporfin and acriflavine via platelets achieves potentiated glioblastoma-targeted photodynamic therapy
- Blog: Zinc-finger protein 471 suppresses gastric cancer through transcriptionally repressing downstream oncogenic PLS3 and TFAP2A
- Blog: Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors
- Blog: Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
- Blog: Inhibition of dihydrotestosterone synthesis in prostate cancer by combined frontdoor and backdoor pathway blockade
- Blog: MicroRNA-647 Targets SRF-MYH9 Axis to Suppress Invasion and Metastasis of Gastric Cancer
- Blog: Triple-Negative Breast Cancer Cells Recruit Neutrophils by Secreting TGF-β and CXCR2 Ligands
- Blog: miR-596-3p suppresses brain metastasis of non-small cell lung cancer by modulating YAP1 and IL-8
- Blog: Distinct DNA Methylation Patterns of Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex
- Blog: Polymorphonuclear myeloid-derived suppressor cells regulates immune recovery during HIV infection through PD-L1 and TGF-β pathways
- Blog: WEE1 inhibitor exerts synergistic effect with KRAS G12C inhibitor via MYBL2-RRM2 axis in KRASG12C-mutant lung cancer
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_dual_pathway_inhibition_1a52fcfe,
title = {dual-pathway inhibition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/dual-pathway-inhibition/rdr_1a52fcfeca8a480885dbca49ee09d0e7},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-22},
}This exact version (version 2, frozen text):
@misc{lacuna_dual_pathway_inhibition_1a52fcfe_v2,
title = {dual-pathway inhibition},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/dual-pathway-inhibition/rdr_1a52fcfeca8a480885dbca49ee09d0e7/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-22},
}